Olaf Kuhlmann

503 total citations
27 papers, 427 citations indexed

About

Olaf Kuhlmann is a scholar working on Oncology, Pharmacology and Pharmacology. According to data from OpenAlex, Olaf Kuhlmann has authored 27 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 11 papers in Pharmacology and 9 papers in Pharmacology. Recurrent topics in Olaf Kuhlmann's work include Drug Transport and Resistance Mechanisms (16 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Olaf Kuhlmann is often cited by papers focused on Drug Transport and Resistance Mechanisms (16 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Olaf Kuhlmann collaborates with scholars based in Switzerland, Germany and United States. Olaf Kuhlmann's co-authors include Stephen Fowler, Michael Derks, Gerd‐Joachim Krauss, Michael Weiß, Katja Heinig, Neil Parrott, Pascale David‐Pierson, Thierry Lavé, Lena E. Friberg and Elisabet I. Nielsen and has published in prestigious journals such as British Journal of Pharmacology, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Olaf Kuhlmann

26 papers receiving 412 citations

Peers

Olaf Kuhlmann
Hans Stieltjes Belgium
Raju D. Amin United States
Robert Iannucci Switzerland
Nobuko Matsushima Japan
Kiyoshi Mihara Japan
P. J. Phillips United Kingdom
Vinayak Hosagrahara United States
Katrijn Bogman Switzerland
Christopher J. Kochansky United States
Haihong Shi United States
Hans Stieltjes Belgium
Olaf Kuhlmann
Citations per year, relative to Olaf Kuhlmann Olaf Kuhlmann (= 1×) peers Hans Stieltjes

Countries citing papers authored by Olaf Kuhlmann

Since Specialization
Citations

This map shows the geographic impact of Olaf Kuhlmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf Kuhlmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf Kuhlmann more than expected).

Fields of papers citing papers by Olaf Kuhlmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olaf Kuhlmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf Kuhlmann. The network helps show where Olaf Kuhlmann may publish in the future.

Co-authorship network of co-authors of Olaf Kuhlmann

This figure shows the co-authorship network connecting the top 25 collaborators of Olaf Kuhlmann. A scholar is included among the top collaborators of Olaf Kuhlmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olaf Kuhlmann. Olaf Kuhlmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Husser, Christophe, Axel Pähler, Mark Seymour, et al.. (2018). Profiling of dalcetrapib metabolites in human plasma by accelerator mass spectrometry and investigation of the free phenothiol by derivatisation with methylacrylate. Journal of Pharmaceutical and Biomedical Analysis. 152. 143–154. 8 indexed citations
2.
Kuhlmann, Olaf, et al.. (2017). Hypersensitivity Reactions to Obinutuzumab in Cynomolgus Monkeys and Relevance to Humans. Toxicologic Pathology. 45(5). 676–686. 13 indexed citations
3.
Kristoffersson, Anders, Pascale David‐Pierson, Neil Parrott, et al.. (2016). Simulation-Based Evaluation of PK/PD Indices for Meropenem Across Patient Groups and Experimental Designs. Pharmaceutical Research. 33(5). 1115–1125. 50 indexed citations
4.
Kuhlmann, Olaf, David Carlile, Johannes Noé, & Darren Bentley. (2014). Interaction potential of Carmegliptin with P-glycoprotein (Pgp) transporter in healthy volunteers. PubMed. 3(1). 28–37. 3 indexed citations
5.
Ishikawa, Tomohiro, Olaf Kuhlmann, Hiroyuki Nemoto, et al.. (2014). Pharmacokinetics and disposition of dalcetrapib in rats and monkeys. Xenobiotica. 44(12). 1117–1126. 6 indexed citations
6.
7.
Phelan, Mary C., Judith Anzures‐Cabrera, David Carlile, et al.. (2013). Effect of Hepatic and Renal Impairment on the Pharmacokinetics of Dalcetrapib. Clinical Pharmacokinetics. 52(4). 255–265. 10 indexed citations
8.
Kuhlmann, Olaf, et al.. (2012). Solubility and stability of dalcetrapib in vehicles and biological media. International Journal of Pharmaceutics. 437(1-2). 103–109. 18 indexed citations
9.
Heinig, Katja, Franz Bucheli, Olaf Kuhlmann, et al.. (2012). Determination of dalcetrapib by liquid chromatography–tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 66. 314–324. 12 indexed citations
10.
Kuhlmann, Olaf, et al.. (2010). Pharmacokinetics and metabolism of the dipeptidyl peptidase IV inhibitor carmegliptin in rats, dogs, and monkeys. Xenobiotica. 40(12). 840–852. 6 indexed citations
11.
Kastelein, John J.P., Agnès Bénardeau, Olaf Kuhlmann, et al.. (2009). Dalcetrapib: no off‐target toxicity on blood pressure or on genes related to the renin‐angiotensin‐aldosterone system in rats. British Journal of Pharmacology. 158(7). 1763–1770. 39 indexed citations
12.
Derks, Michael, Stephen Fowler, & Olaf Kuhlmann. (2009). A single-center, open-label, one-sequence study of dalcetrapib coadministered with ketoconazole, and an in vitro study of the S-methyl metabolite of dalcetrapib. Clinical Therapeutics. 31(3). 586–599. 24 indexed citations
13.
Kuentz, Martin, Nicole Wyttenbach, & Olaf Kuhlmann. (2007). Application of a Statistical Method to the Absorption of a New Model Drug from Micellar and Lipid Formulations—Evaluation of Qualitative Excipient Effects. Pharmaceutical Development and Technology. 12(3). 275–283. 16 indexed citations
14.
Dongowski, G., et al.. (2005). The influence of bile salts and mixed micelles on the pharmacokinetics of quinine in rabbits. European Journal of Pharmaceutics and Biopharmaceutics. 60(1). 147–151. 36 indexed citations
15.
Kuhlmann, Olaf, et al.. (2001). Konzentrationsverlauf von Diclofenac im Kammerwasser und im Plasma bei i.v. Applikation vor der Kataraktextraktion bei 59 Patienten - eine prospektive Studie12. Klinische Monatsblätter für Augenheilkunde. 218(2). 85–88. 4 indexed citations
16.
Weiss, Michael A., Olaf Kuhlmann, Daniel Y. Hung, & Michael S. Roberts. (2000). Cytoplasmic binding and disposition kinetics of diclofenac in the isolated perfused rat liver. British Journal of Pharmacology. 130(6). 1331–1338. 24 indexed citations
17.
Kuhlmann, Olaf, Stefan G. Hofmann, & Michael Weiß. (1999). Determination of idarubicin and idarubicinol in rat plasma using reversed-phase high-performance liquid chromatography and fluorescence detection. Journal of Chromatography B Biomedical Sciences and Applications. 728(2). 279–282. 22 indexed citations
18.
Weiß, Michael, et al.. (1998). Hepatocellular distribution and elimination kinetics of diclofenac in the isolated perfused rat liver. Naunyn-Schmiedeberg s Archives of Pharmacology. 357(4). 1 indexed citations
19.
Kuhlmann, Olaf, et al.. (1998). Simultaneous determination of diclofenac and oxybuprocaine in human aqueous humor with HPLC and electrochemical detection. Journal of Pharmaceutical and Biomedical Analysis. 17(8). 1351–1356. 32 indexed citations
20.
Kuhlmann, Olaf & Gerd‐Joachim Krauss. (1997). Crocheted ETFE-reactor for on-line post-column photoderivatization of diclofenac in high-performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis. 16(4). 553–559. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hans Stieltjes Breakdown of academic impact, for papers by Raju D. Amin Breakdown of academic impact, for papers by Robert Iannucci Breakdown of academic impact, for papers by Nobuko Matsushima Breakdown of academic impact, for papers by Kiyoshi Mihara Breakdown of academic impact, for papers by P. J. Phillips Breakdown of academic impact, for papers by Vinayak Hosagrahara Breakdown of academic impact, for papers by Katrijn Bogman Breakdown of academic impact, for papers by Christopher J. Kochansky Breakdown of academic impact, for papers by Haihong Shi
Rankless by CCL
2026